EC approves GSK’s Jemperli-chemo combo for endometrial cancer
The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin and paclitaxel for the first-line…
News
$590m to Moderna from HHS for mRNA ‘flu vax development
KeyMed partners with US-based biotech Prolium in bispecific antibody deal
Arrowhead’s plozasiran set for FDA review as Tryngolza challenge looms
AstraZeneca secures first BTK approval in first-line mantle cell lymphoma
Feinstein Institutes gains NIH grant to explore ghrelin for GI-ARS
FDA approves Amgen’s combo therapy for colorectal cancer
Shionogi awarded $375m from HHS for preventative Covid-19 injectable
